Taiwan FDA approves Chugai Pharma’s PiaSky for subcutaneous treatment of patients with paroxysmal nocturnal hemoglobinuria: Tokyo Tuesday, May 20, 2025, 10:00 Hrs [IST] Chugai P ...

Let's see what has spooked investors today and caused them to push the sell button. The post Down 5%: What's going on with ...